Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily A Vertosick

Showing results (1-10 of 89) with videos related to

Pageof 9
Sort By:
BMC Sports Science, Medicine & Rehabilitation|August 30, 2016
An empirical study of race times in recreational endurance runnersAndrew J Vickers, Emily A Vertosick
European Urology|May 11, 2020
Reply to Jianhui Du, Yueguang Liu, and Weigang Yan's Letter to the Editor re: Gregory T. Chesnut, Emily A. Vertosick, Nicole Benfante, et al. Role of Changes in Magnetic Resonance Imaging or Clinical Stage in Evaluation of Disease Progression for Men with Prostate Cancer on Active Surveillance. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2019.12.009Gregory T Chesnut, Emily A Vertosick, Behfar Ehdaie
Cancer Epidemiology|October 17, 2017
A systematic review of instrumental variable analyses using geographic region as an instrumentEmily A Vertosick, Melissa Assel, Andrew J Vickers
European Urology|June 16, 2018
Value of a Statistical Model Based on Four Kallikrein Markers in Blood, Commercially Available as 4Kscore, in All Reasonable Prostate Biopsy SubgroupsAndrew J Vickers, Emily A Vertosick, Daniel D Sjoberg
The Journal of Urology|March 20, 2014
Relative value of race, family history and prostate specific antigen as indications for early initiation of prostate cancer screeningEmily A Vertosick, Bing Ying Poon, Andrew J Vickers
Urologic Oncology|October 5, 2016
Reply to Williamson S.R. What is the malignant potential of clear cell papillary renal cell carcinoma? Urol Oncol 2016; 34: 420Daniel P Nguyen, A Ari Hakimi, Emily A Vertosick, et al.
BJU International|May 27, 2018
Effects of pathological upstaging or upgrading on metastasis and cancer-specific mortality in men with clinical low-risk prostate cancerEvan Kovac, Emily A Vertosick, Daniel D Sjoberg, et al.
European Urology Oncology|June 4, 2019
Performance Prediction for Surgical Outcomes in Partial Nephrectomy Using Nephrometry Scores: A Comparison of Arterial Based Complexity (ABC), RENAL, and PADUA SystemsRicardo G Alvim, François Audenet, Emily A Vertosick, et al.
Urology|July 29, 2023
The Association Between Low Preoperative Serum Testosterone and Post-radical Prostatectomy Urinary FunctionM Paula Domino, Emily A Vertosick, Andrew J Vickers, et al.
Asia-Pacific Journal of Oncology Nursing|October 2, 2019
Preoperative Anxiety in Patients Undergoing Outpatient Cancer SurgeryJennifer Ross Majumdar, Emily A Vertosick, Bevin Cohen, et al.
Pageof 9

Showing results (1-10 of 89) with videos related to

Sort By:
Pageof 9
BMC Sports Science, Medicine & Rehabilitation|August 30, 2016
An empirical study of race times in recreational endurance runnersAndrew J Vickers, Emily A Vertosick
European Urology|May 11, 2020
Reply to Jianhui Du, Yueguang Liu, and Weigang Yan's Letter to the Editor re: Gregory T. Chesnut, Emily A. Vertosick, Nicole Benfante, et al. Role of Changes in Magnetic Resonance Imaging or Clinical Stage in Evaluation of Disease Progression for Men with Prostate Cancer on Active Surveillance. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2019.12.009Gregory T Chesnut, Emily A Vertosick, Behfar Ehdaie
Cancer Epidemiology|October 17, 2017
A systematic review of instrumental variable analyses using geographic region as an instrumentEmily A Vertosick, Melissa Assel, Andrew J Vickers
European Urology|June 16, 2018
Value of a Statistical Model Based on Four Kallikrein Markers in Blood, Commercially Available as 4Kscore, in All Reasonable Prostate Biopsy SubgroupsAndrew J Vickers, Emily A Vertosick, Daniel D Sjoberg
The Journal of Urology|March 20, 2014
Relative value of race, family history and prostate specific antigen as indications for early initiation of prostate cancer screeningEmily A Vertosick, Bing Ying Poon, Andrew J Vickers
Urologic Oncology|October 5, 2016
Reply to Williamson S.R. What is the malignant potential of clear cell papillary renal cell carcinoma? Urol Oncol 2016; 34: 420Daniel P Nguyen, A Ari Hakimi, Emily A Vertosick, et al.
BJU International|May 27, 2018
Effects of pathological upstaging or upgrading on metastasis and cancer-specific mortality in men with clinical low-risk prostate cancerEvan Kovac, Emily A Vertosick, Daniel D Sjoberg, et al.
European Urology Oncology|June 4, 2019
Performance Prediction for Surgical Outcomes in Partial Nephrectomy Using Nephrometry Scores: A Comparison of Arterial Based Complexity (ABC), RENAL, and PADUA SystemsRicardo G Alvim, François Audenet, Emily A Vertosick, et al.
Urology|July 29, 2023
The Association Between Low Preoperative Serum Testosterone and Post-radical Prostatectomy Urinary FunctionM Paula Domino, Emily A Vertosick, Andrew J Vickers, et al.
Asia-Pacific Journal of Oncology Nursing|October 2, 2019
Preoperative Anxiety in Patients Undergoing Outpatient Cancer SurgeryJennifer Ross Majumdar, Emily A Vertosick, Bevin Cohen, et al.
Pageof 9